Furuse, J., Gemma, A., Ichikawa, W., Okusaka, T., Seki, A., & Ishii, T. (2017). Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis. Jpn J Clin Oncol.
Styl ChicagoFuruse, Junji, Akihiko Gemma, Wataru Ichikawa, Takuji Okusaka, Akihiro Seki, a Tadashi Ishii. "Postmarketing Surveillance Study of Erlotinib Plus Gemcitabine for Pancreatic Cancer in Japan: POLARIS Final Analysis." Jpn J Clin Oncol 2017.
Citace podle MLAFuruse, Junji, et al. "Postmarketing Surveillance Study of Erlotinib Plus Gemcitabine for Pancreatic Cancer in Japan: POLARIS Final Analysis." Jpn J Clin Oncol 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..